Genzyme, Sanofi negotiations remain in low gear

Biotechnology company Genzyme (NASDAQ: GENZ) may be holding out for more money from suitor Sanofi-Aventis (NYSE: SNY), but  it could find it difficult to persuade investors it is better off on its own. Report